CompletedNot Applicable

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle

United States61 participantsStarted 2016-12-16

Plain-language summary

The goal of this clinical research study is to compare the effectiveness of a smaller, 25-gauge needle when used in an endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) instead of a standard 22-gauge needle. The safety of the needles will also be studied.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 18 years or older
✓. Indication for EBUS-guided needle biopsy based on suspicion of either benign or malignant disease in mediastinal or hilar lymph nodes.

Exclusion criteria

✕. Patients who are pregnant or lactating
✕. Inability to give informed consent
✕. Patients in which only one lymph node station is expected to be sampled by the performing clinician.

What they're measuring

Percentage of Lymph Nodes With Adequate Samples

Timeframe: One to two hours.

Trial details

NCT IDNCT03004586

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-06-25

Results submitted2021-06-22

View on ClinicalTrials.gov More Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma trials